Arai, Alshera M.
HRN: 24-48-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2024
AMPICILLIN 500MG (VIAL)
02/07/2024
02/13/2024
IV
150mg
Q12hours
PSNB (non-institutional Delivery)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes